164 related articles for article (PubMed ID: 23978553)
1. TMT-HCC: a tool for text mining the biomedical literature for hepatocellular carcinoma (HCC) biomarkers identification.
Abul Seoud RA; Mabrouk MS
Comput Methods Programs Biomed; 2013 Dec; 112(3):640-8. PubMed ID: 23978553
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.
Jia D; Wei L; Guo W; Zha R; Bao M; Chen Z; Zhao Y; Ge C; Zhao F; Chen T; Yao M; Li J; Wang H; Gu J; He X
Hepatology; 2011 Oct; 54(4):1227-36. PubMed ID: 21688285
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in tumor markers of human hepatocellular carcinoma.
Yoon SK
Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
[TBL] [Abstract][Full Text] [Related]
5. Specific molecular markers in hepatocellular carcinoma.
Yao DF; Dong ZZ; Yao M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
7. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
Wang X; Zhang A; Sun H
Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
Ma L; Ji L; Yu Y; Wang J
Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
[TBL] [Abstract][Full Text] [Related]
11. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
[TBL] [Abstract][Full Text] [Related]
12. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
[TBL] [Abstract][Full Text] [Related]
13. Future of molecular profiling of human hepatocellular carcinoma.
Roessler S; Budhu A; Wang XW
Future Oncol; 2007 Aug; 3(4):429-39. PubMed ID: 17661718
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
Gonzalez SA; Keeffe EB
Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
[TBL] [Abstract][Full Text] [Related]
15. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
16. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
[TBL] [Abstract][Full Text] [Related]
17. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
18. Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Liu T; Xue R; Dong L; Wu H; Zhang D; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):45-51. PubMed ID: 21138899
[TBL] [Abstract][Full Text] [Related]
19. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
20. High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P; Singh OV
Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
